Loading...
Presentation and Treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome)
INTRODUCTION: Mucopolysaccharidosis Type II (MPS II; Hunter syndrome) is an X- linked lysosomal storage disorder caused by a deficiency of iduronate-2-sulfatase (IDS). IDS deficiency leads to primary accumulation of dermatan sulfate (DS) and heparan sulfate (HS). MPS II is both multi-systemic and pr...
Na minha lista:
| Udgivet i: | Expert Opin Orphan Drugs |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5693349/ https://ncbi.nlm.nih.gov/pubmed/29158997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21678707.2017.1296761 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|